The US Food and Drug Administration (FDA) is watching for potential drug shortages after India restricted exports of some medicines. The list of 26 restricted ingredients and medicines includes paracetamol and several antibiotics, such as tinidazole and erythromycin, the hormone progesterone and Vitamin B12. In the US, Indian imports accounted for 24% of medicines and 31% of ingredients in 2018.